coronavirus is widely believed to be one of the keys to helping the world get back to normal after the devastating impact of the pandemic.
The UK now has access to six different Covid-19 vaccine candidates in development, across four different types, representing some 340 million doses, although the Astra Zeneca-Oxford University vaccine trial was briefly paused this month after a side effect was reported in a patient in the UK.A week ago (September 12), it was revealed the trial will resume across sites in the UK as Oxford University said: "Ongoing randomised controlled clinical trials of the Oxford coronavirus vaccine ChAdOx1 nCoV-19 will resume across all UK clinical trial sites."Globally some 18,000 individuals have received study.